Acute and chronic cardiac toxicity is the most perplexing reaction of doxorubicin. The acute syndrome is characterised by rhythm disturbances, electrocardiographic abnormalities and occasionally acute cardiac dilatation. The chronic damage is dose-dependent and can lead to congestive heart failure. 4'-epidoxorubicin (epirubicin) has been claimed to be less cardiotoxic than doxorubicin, but the advantage is not quantitatively impressive (Chabner & Myers, 1989) .
Magnesium (Mg) is essential for activation of NA+/K+ ATPase pump, which plays a major role in regulating NA+/K+ transport and in maintaining resting membrane potentials (Altura BM and Altura BT, 1984) . The direct and indirect (through the effects on K+ and Ca"+ metabolism)
cardioprotective and antiarrhythmic properties of Mg are well known (Dyckner & Wester, 1982; Iseri, 1984) . Mg deficit is associated with ventricular and supraventricular arrhythmias, symptoms of cardiac failure and electrocardiographic modifications, such low QRS voltages, extended Q-T interval and ST-T tract abnormalities (Dyckner & Wester, 1979; Dickner & Wester, 1982; Chen Wan Chun et al., 1982; Rasmussen et al., 1986) .
Mg is mainly an intracellular cation; intracellular deficit is often not revealed by measurement of serum levels (Iseri, 1984; Ryzen et al., 1986; Abbasciano et al., 1988) (Locatelli et al., 1987) ; the other parameters were assayed using standard laboratory methods.
During the period of observation all patients received the same dietary regimen to avoid differences in Mg intake; no diuretic was administered (with the exception of intravenous furosemide 20 mg in two cases treated with the schedule cisplatin + doxorubicin + cyclophosphamide). Vomiting was controlled by intravenous metoclopramide or methylprednisolone, which do not interfere with Mg homeostasis when acutely administered (Quanne & Dirks, 1983) . Each patient had daily clinical and electrocardiographic evaluation, which were done always by the same physician to ensure homogeneity in evaluating cardiac changes; the increase of 20% or more in heart rate from pretreatment values was considered as a 'minor' change; symptoms of cardiac insufficiency, rhythm disturbances and electrocardiogram (ECG) abnormalities were considered as 'major' changes. The number of vomiting episodes and the possible onset of diarrhoea was also registered for each patient. Clinicalelectrocardiographic evaluation and EMg assay were done blind by two different physicians.
Essential results of the study are reported in Table I . Serum levels of Mg, Na, K, Cl, Ca, LDH, CPK, AST and ALT did not show significant changes. No symptoms of cardiac failure were observed. Four patients had increase of 20% or more in heart rate and four had 'major' changes; all cardiac disturbances were observed within 48 h from doxorubicin or epirubicin administration. EMg increased within 48 h in 15 patients and decreased in 11. Only one patient with increased EMg had 'minor' changes, whereas seven out of 11 patients (63.6%) with reduced EMg had cardiac disturbances; three out of four 'major' changes were observed in the patients who had the more marked reduction in EMg. The difference is statistically significant either considering the whole frequency of cardiac disturbances (P <0.01, using Fisher's exact test) or considering the distribution in two classes of severity (P < 0.05, using chi-square test cardiotoxicity. Most of the existing evidence supports freeradicals formation as the basis for acute cardiotoxicity induced by anthracyclines; moreover doxorubicin reduces glutathione peroxidase activity, a key enzyme in the detoxication of peroxides (Myers et al., 1985; Chabner & Myers, 1989) . Anthracyclines also have a direct action on cell membrane, causing fluidity changes and alterating the organisation of membrane phospholipids (Myers et al., 1985) . Mg has a stabilising effect for the cell membrane; its complexing with phospholipids reduces membrane fluidity and permeability (Durlach, 1988) . Moreover Mg is pivotal in the synthesis of glutathione and in the transfer, storage and utilisation of energy, regulates redox reactions and maintains the coupling of oxidation and phosphorylation in mitochondria (Iseri, 1984; Durlach, 1988) . All these functions could be useful in protecting myocardial cells against anthracyclineinduced injury, and it is possible that the cell requirement of Mg increases during the administration of doxorubicin and epirubicin, to counterbalance the toxic effects of the drugs. In some predisposed patients the cells might be unable to increase their Mg content, owing to enhanced susceptibility to the direct action of anthracyclines on cell membrane, with formation of covalent bindings to membrane structures (Myers et al., 1985) and consequent leakage of membrane Mg and/or inability of the cells to uptake serum Mg. The risk of acute cardiotoxicity would be higher in such patients: indeed we obserged 'major' ECG changes only in patients with reduced EMg. Prolonged infusion of doxorubicin seems to reduce chronic cardiotoxicity (Speyer et al., 1985) . This observation supports the hypothesis that cardiotoxicity is related to repeated high concentrations of the drug, which would induce an acute myocarditis-like effect (Shapira et al., 1990) , rather than to the total cumulative dose (Alexander et al., 1979) : the sum of repeated acute toxic effects would lead to the chronic damage (Piver et al., 1985) . Our preliminary data suggest a relationship between intracellular Mg concentrations and anthracycline-induced acute toxic effects on the heart: might the monitoring of intracellular Mg levels have some value in predicting the development of the chronic damage? More work is necessary to test this idea.
